Octapharma presents research on congenital & acquired bleeding disorders at ASH Meeting ...Middle East

Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for Intravenous Use in the treatment of congenital and acquired bleeding disorders during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, a virtual medical congress to be held December 5 - 8, 2020.

Hence then, the article about octapharma presents research on congenital acquired bleeding disorders at ash meeting was published today ( Thursday 03/12/2020 - 09:00 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Octapharma presents research on congenital & acquired bleeding disorders at ASH Meeting )

Also on site :

• I-70 closed in Glenwood Canyon for safety concerns, police activity
• Iran protests latest: Trump to be briefed on military strike options after he orders new sanctions on Tehran
• What we know about the alleged arson at Mississippi’s largest and oldest synagogue